OCULOGICA

Oculogica is a neuro-diagnostic medical device company based in New York, founded in 2013 by neurosurgeon Dr.

Uzma Samadani. The company focuses on advancing the objective assessment of brain injuries, such as concussions and traumatic brain injury (TBI), using innovative eye-tracking technology. Their flagship product, the EyeBOX®, is the first FDA-cleared, non-invasive device that aids in diagnosing concussions without the need for a pre-injury baseline test or verbal input. The EyeBOX® tracks over 100,000 data points related to eye movement while patients watch a short video, generating a "BOX score" that indicates the presence or absence of a concussion. It is suitable for a wide age range, from children to adults, and is utilized in various settings, including emergency departments, sports medicine, and military contexts. Oculogica's technology supports healthcare professionals in making rapid, informed decisions regarding brain health and recovery monitoring.